G. Görgişen Et Al. , "Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients," EMBL Cancer Genomics , Heidelberg, Germany, pp.1, 2013
Görgişen, G. Et Al. 2013. Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients. EMBL Cancer Genomics , (Heidelberg, Germany), 1.
Görgişen, G., PEHIVANOGLU, S., Cetin, Z., ERDOGAN, A., & Özeş, O. N., (2013). Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients . EMBL Cancer Genomics (pp.1). Heidelberg, Germany
Görgişen, Gökhan Et Al. "Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients," EMBL Cancer Genomics, Heidelberg, Germany, 2013
Görgişen, Gökhan Et Al. "Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients." EMBL Cancer Genomics , Heidelberg, Germany, pp.1, 2013
Görgişen, G. Et Al. (2013) . "Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients." EMBL Cancer Genomics , Heidelberg, Germany, p.1.
@conferencepaper{conferencepaper, author={Gökhan Görgişen Et Al. }, title={Screening of insulin receptor substrate 1 carboxy terminal domain variations in non small cell lung cancer (NSCLC) patients}, congress name={EMBL Cancer Genomics}, city={Heidelberg}, country={Germany}, year={2013}, pages={1} }